Float Short %

5.71

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

0.06

EPS Last/This Y

0.29

EPS This/Next Y

-0.02

Price

2.43

Target Price

7.08

Analyst Recom

1.57

Performance Q

Relative Volume

0.5

Beta

2.53

Ticker: CDXS

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	CDXS	3.02	0.09	0.60	1704
2025-08-18	CDXS	3.01	0.07	0.00	1510
2025-08-19	CDXS	2.88	0.04	0.00	2635
2025-08-20	CDXS	2.82	0.04	0.00	2730
2025-08-21	CDXS	2.83	0.03	4.82	2863
2025-08-22	CDXS	2.88	0.05	0.02	2900
2025-08-25	CDXS	2.67	0.05	0.00	2917
2025-08-26	CDXS	2.63	0.05	0.09	2923
2025-08-27	CDXS	2.67	0.05	0.00	2939
2025-08-28	CDXS	2.71	0.05	0.00	2958
2025-08-29	CDXS	2.74	0.05	0.00	2958
2025-09-02	CDXS	2.51	0.05	0.09	2954
2025-09-03	CDXS	2.41	0.05	0.26	2962
2025-09-04	CDXS	2.42	0.05	1.35	3001
2025-09-05	CDXS	2.41	0.08	0.01	3157
2025-09-08	CDXS	2.45	0.09	0.13	2731
2025-09-09	CDXS	2.45	0.09	0.20	2736
2025-09-10	CDXS	2.43	0.10	0.00	2804
2025-09-11	CDXS	2.44	0.10	0.00	2780
2025-09-12	CDXS	2.43	0.10	0.00	2778
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	CDXS	3.02	52.5	-	-0.65
2025-08-18	CDXS	3.00	52.9	-	-0.65
2025-08-19	CDXS	2.87	52.9	-	-0.65
2025-08-20	CDXS	2.81	52.9	-	-0.65
2025-08-21	CDXS	2.83	52.9	-	-0.65
2025-08-22	CDXS	2.89	56.3	-	-0.60
2025-08-25	CDXS	2.67	56.3	-	-0.60
2025-08-26	CDXS	2.63	56.3	-	-0.60
2025-08-27	CDXS	2.67	56.3	-	-0.60
2025-08-28	CDXS	2.72	56.3	-	-0.60
2025-08-29	CDXS	2.74	56.3	-	-0.60
2025-09-02	CDXS	2.51	56.3	-	-0.60
2025-09-03	CDXS	2.42	56.3	-	-0.60
2025-09-04	CDXS	2.42	56.3	-	-0.60
2025-09-05	CDXS	2.42	56.3	-	-0.60
2025-09-08	CDXS	2.45	56.3	-	-0.60
2025-09-09	CDXS	2.45	56.3	-	-0.60
2025-09-10	CDXS	2.43	56.3	-	-0.60
2025-09-11	CDXS	2.44	56.3	-	-0.60
2025-09-12	CDXS	2.43	56.3	-	-0.60
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	CDXS	150.70	14.45	6.94
2025-08-18	CDXS	138.31	11.36	6.37
2025-08-19	CDXS	138.31	11.36	6.37
2025-08-20	CDXS	138.31	11.36	6.37
2025-08-21	CDXS	138.31	11.36	6.37
2025-08-22	CDXS	138.31	11.36	6.37
2025-08-25	CDXS	138.31	6.25	6.37
2025-08-26	CDXS	138.31	6.25	6.37
2025-08-27	CDXS	138.31	6.25	5.93
2025-08-28	CDXS	138.31	6.25	5.93
2025-08-29	CDXS	138.31	6.25	5.93
2025-09-02	CDXS	138.31	6.25	5.93
2025-09-03	CDXS	138.31	6.25	5.93
2025-09-04	CDXS	138.31	6.25	5.93
2025-09-05	CDXS	131.28	6.25	5.93
2025-09-08	CDXS	128.93	6.26	5.93
2025-09-09	CDXS	128.93	6.26	5.93
2025-09-10	CDXS	128.93	6.26	5.93
2025-09-11	CDXS	125.32	6.26	5.71
2025-09-12	CDXS	125.32	6.26	5.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.16

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

125.32

Institutional Transactions

6.26

Beta

2.53

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.2

Max Drawdown 5-Year %

-96.4

Target Price

7.08

P/E

Forward P/E

PEG

P/S

3.84

P/B

3.94

P/Free Cash Flow

EPS

-0.82

Average EPS Est. Cur. Y

-0.6

EPS Next Y. (Est.)

-0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-113.67

Relative Volume

0.5

Return on Equity vs Sector %

-141.7

Return on Equity vs Industry %

-128.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 188

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y